AI Integration of Multi-omics Data for Drug Target Prediction in Glioblastoma
Glioblastoma (GBM) is an aggressive primary brain tumor with marked molecular and cellular heterogeneity, and current treatment provides limited long-term disease control. Single-target therapies have frequently failed because tumor subpopulations can differ in signaling dependencies, adapt under treatment pressure, an...